Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 19 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2020 Filed Feb 20, 2020 21:00 UTC |
STARR CHRISTOPHER MDirector
|
GrantRestricted Stock Units · Derivative | 1,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001795 · section16.xml · derivative · entry 1 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289 Underlying: Common Stock · 1,289 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. F1 · derivative.expiration_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:54 UTC |
KLAUSNER ARTHUR JDirector
|
GrantStock Options · Derivative | 5,646 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001654954-20-001791 · section16.xml · derivative · entry 2 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,646 Underlying: Common Stock · 5,646 shares Expires 2030-01-31 F2 · derivative.exercise_date: Stock options vest 25% on March 31, 2020, 25% on June 30, 2020, 25% on September 30, 2020, and 25% on December 31, 2020. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:54 UTC |
KLAUSNER ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 1,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001791 · section16.xml · derivative · entry 1 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289 Underlying: Common Stock · 1,289 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. F1 · derivative.expiration_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 02:02 UTC |
Tsuchimoto Kim RChief Financial Officer
|
GrantStock Options · Derivative | 20,455 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001654954-20-001796 · section16.xml · derivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,455 Underlying: Common Stock · 20,455 shares Expires 2030-01-31 F2 · derivative.exercise_date: Stock Options vest 6/48ths on the 6-month anniversary of vesting commencement date of January 1, 2020, and 1/48th per month thereafter. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 02:02 UTC |
Tsuchimoto Kim RChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 4,923 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001796 · section16.xml · derivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,923 Underlying: Common Stock · 4,923 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. F1 · derivative.expiration_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:57 UTC |
Anderson RaymondDirector
|
GrantStock Options · Derivative | 5,646 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001654954-20-001793 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,646 Underlying: Common Stock · 5,646 shares Expires 2030-01-31 F2 · derivative.exercise_date: Stock options vest 25% on March 31, 2020, 25% on June 30, 2020, 25% on September 30, 2020, and 25% on December 31, 2020. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:57 UTC |
Anderson RaymondDirector
|
GrantRestricted Stock Units · Derivative | 1,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001793 · section16.xml · derivative · entry 1 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289 Underlying: Common Stock · 1,289 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. F1 · derivative.expiration_date: Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:58 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 111,753 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001654954-20-001794 · section16.xml · derivative · entry 2 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,753 Underlying: Common Stock · 111,753 shares Expires 2030-01-31 F2 · derivative.exercise_date: Stock options vest 6/48ths on the 6-month anniversary of vesting commencement date of January 1, 2020, and 1/48th per month thereafter Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:58 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 26,895 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001794 · section16.xml · derivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,895 Underlying: Common Stock · 26,895 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. F1 · derivative.expiration_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:55 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
GrantStock Options · Derivative | 32,193 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001654954-20-001792 · section16.xml · derivative · entry 2 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,193 Underlying: Common Stock · 32,193 shares Expires 2030-01-31 F2 · derivative.exercise_date: Stock options vest 6/48ths on the 6-month anniversary of vesting commencement date of January 1, 2020, and 1/48th per month thereafter Read SEC document |
| January 31, 2020 Filed Feb 21, 2020 01:55 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 7,748 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-001792 · section16.xml · derivative · entry 1 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,748 Underlying: Common Stock · 7,748 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. F1 · derivative.expiration_date: Restricted stock units vest 25% on January 1, 2021, 25% on January 1, 2022, 25% on January 1, 2023, and 25% on January 1, 2024. Read SEC document |
| January 30, 2020 Filed Feb 21, 2020 02:05 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
GrantStock Options · Derivative | 6,125 | $0.00 Strike: $16.80 | $0.00 |
DisclosureSEC source: 0001654954-20-001798 · section16.xml · derivative · entry 1 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,125 Underlying: Common Stock · 6,125 shares Expires 2030-01-30 F1 · derivative.exercise_date: Stock Options vesting commenced on January 1, 2020 as follows: 510 on January 31, 2020 and each subsequent month-end thereafter. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 18:33 UTC |
Tactic Pharma LLC10% owner
Mazar Andrew PaulDirector · Chief Scientific Officer · 10% owner
Robinson ChandlerDirector · Chief Executive Officer · 10% owner
O'Halloran Thomas V.10% owner
Brown Michael JDirector · 10% owner
|
PurchaseCommon stock | 125,000 | $8.00 | $1,000,000.00 |
DisclosureSEC source: 0001654954-19-014150 · section16.xml · nonDerivative · entry 1 Tactic Pharma LLC · CIK 0001727357 · 10% owner Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer · 10% owner Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer · 10% owner O'Halloran Thomas V. · CIK 0001727481 · 10% owner Brown Michael J · CIK 0001035909 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,667 F1 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 18:32 UTC |
Leo Karl10% owner
|
PurchaseCommon stock | 313.75 | $8.00 | $2,510.00 |
DisclosureSEC source: 0001654954-19-014149 · section16.xml · nonDerivative · entry 2 Leo Karl · CIK 0001727480 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313.75 Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 18:32 UTC |
Leo Karl10% owner
|
PurchaseCommon stock | 156,250 | $8.00 | $1,250,000.00 |
DisclosureSEC source: 0001654954-19-014149 · section16.xml · nonDerivative · entry 1 Leo Karl · CIK 0001727480 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1 Disclosed balance after: 156,250 F1 · ownership.nature: This is based upon the 156,250 shares of Monopar Common Stock that KWL Investments II, LLC directly owns. As a manager of KWL Investments II, LLC, Mr. Leo may be deemed to share voting and dispositive power over these 156,250 shares. Mr. Leo disclaims beneficial ownership of the 156,250 shares held by KWL Investments II, LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 19:10 UTC |
Hendricks Diane10% owner
|
PurchaseCommon stock | 468,750 | $8.00 | $3,750,000.00 |
DisclosureSEC source: 0001654954-19-014155 · section16.xml · nonDerivative · entry 1 Hendricks Diane · CIK 0001727478 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1 Disclosed balance after: 468,750 F1 · ownership.nature: This is based upon the 468,750 shares of Monopar Common Stock that DMH Business LLC directly owns. As a manager of DMH Business LLC, Ms. Hendricks may be deemed to share voting and dispositive power over these 468,750 shares. Ms. Hendricks disclaims beneficial ownership of the 468,750 shares held by DMH Business LLC, except to the extent of her pecuniary interest therein. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:30 UTC |
Tsuchimoto Kim RChief Financial Officer
|
PurchaseCommon stock | 325 | $8.00 | $2,600.00 |
DisclosureSEC source: 0001654954-19-014148 · section16.xml · nonDerivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325 Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 00:40 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
Exercise / conversionStock options · Derivative | 100 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-013406 · section16.xml · derivative · entry 4 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 Underlying: Common Stock · 100 shares Expires 2026-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Original stock options to purchase up to 7,000 shares of common stock vested: 1,190 shares on January 15, 2017; 1,120 shares on February 15, 2017; 1,190 shares on March 15, 2017; 1,120 shares on April 15, 2017; 1,190 shares on May 15, 2017; and 1,190 shares on June 15, 2017. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 00:40 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
Exercise / conversionStock options · Derivative | 18,333 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-19-013406 · section16.xml · derivative · entry 3 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,671 Underlying: Common Stock · 18,333 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Original stock options to purchase up to 32,004 shares of common stock vested 12,000 shares upon grant date of January 1, 2018 and 1,667 shares on the first of each month thereafter. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 00:40 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
Exercise / conversionCommon Stock | 100 | $0.00 | $0.10 |
DisclosureSEC source: 0001654954-19-013406 · section16.xml · nonDerivative · entry 2 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 00:40 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
Exercise / conversionCommon Stock | 18,333 | $6.00 | $109,998.00 |
DisclosureSEC source: 0001654954-19-013406 · section16.xml · nonDerivative · entry 1 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2018 Filed Jan 26, 2019 01:58 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
GrantStock option · Derivative | 20,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-19-000796 · section16.xml · derivative · entry 1 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common stock · 20,000 shares Expires 2028-12-30 F1 · derivative.exercise_date: Stock options vest and become exercisable according to the following schedule: 1,667 shares vest on January 31, 2019 and the last day of each subsequent month thereafter. Read SEC document |
| August 28, 2018 Filed Sep 27, 2018 23:10 UTC Amendment |
Tsuchimoto Kim RChief Financial Officer
|
GrantStock options · Derivative | 41,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010580 · section16.xml · derivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,100 Underlying: Common Stock · 41,100 shares Expires 2028-08-27 F1 · derivative.exercise_date: Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter. Read SEC document |
| August 28, 2018 Filed Sep 27, 2018 18:31 UTC |
Tsuchimoto Kim RChief Financial Officer
|
GrantStock options · Derivative | 41,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010546 · section16.xml · derivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,620 Underlying: Common stock · 41,100 shares Expires 2028-08-27 F1 · derivative.exercise_date: Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 18:45 UTC |
Brown Michael JDirector · 10% owner
|
GrantStock options · Derivative | 26,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010577 · section16.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,100 Underlying: Common stock · 26,100 shares Expires 2028-08-08 F3 · derivative.exercise_date: Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 18:39 UTC |
STARR CHRISTOPHER MDirector
|
GrantStock options · Derivative | 26,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010575 · section16.xml · derivative · entry 2 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,100 Underlying: Common stock · 26,100 shares Expires 2028-08-08 F2 · derivative.exercise_date: Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 22:42 UTC |
KLAUSNER ARTHUR JDirector
|
GrantStock options · Derivative | 26,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010576 · section16.xml · derivative · entry 3 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,100 Underlying: Common stock · 26,100 shares Expires 2028-08-08 F2 · derivative.exercise_date: Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 22:49 UTC |
Anderson RaymondDirector
|
GrantStock options · Derivative | 26,100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010578 · section16.xml · derivative · entry 2 Anderson Raymond · CIK 0001362489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,100 Underlying: Common stock · 26,100 shares Expires 2028-08-08 F1 · derivative.exercise_date: Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 22:35 UTC |
Robinson ChandlerDirector · Chief Executive Officer · 10% owner
|
GrantStock options · Derivative | 145,500 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010574 · section16.xml · derivative · entry 4 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,500 Underlying: Common stock · 145,500 shares Expires 2028-08-08 F3 · derivative.exercise_date: Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter. Read SEC document |
| August 09, 2018 Filed Sep 27, 2018 22:32 UTC |
Mazar Andrew PaulDirector · Chief Scientific Officer · 10% owner
|
GrantStock options · Derivative | 134,300 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001654954-18-010573 · section16.xml · derivative · entry 4 Mazar Andrew Paul · CIK 0001727393 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,300 Underlying: Common stock · 134,300 shares Expires 2028-08-08 F3 · derivative.exercise_date: Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.